Morellco Pharma A/S — Credit Rating and Financial Key Figures

Morellco Pharma A/S (CVR number: 40651055) is a company from FREDERICIA. The company recorded a gross profit of 270.8 kDKK in 2020. The operating profit was 9.4 kDKK, while net earnings were 1.9 kDKK. The profitability of the company measured by Return on Assets (ROA) was 1.5 %, which can be considered weak and Return on Equity (ROE) was 0.5 %, which can be considered weak. The equity ratio, a key indicator for solidity, stood at 63.2 %, a level that can be considered to be good. This shows that a large part of the company's assets are funded by shareholders' equity, reducing financial risk. Morellco Pharma A/S's liquidity measured by quick ratio was 2.4 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.